milestone

related words
unproven
protein
tm
therapeutic
distributing
discovered
pti
tarceva
gene
nexavar
surgeon
novel
hematide
stent
undergo
esw
recothrom
formulation
bidil
myvax
related documents
1359555--3/28/2008--ICO_Global_Communications_(Holdings)_LTD
1318310--2/25/2010--ev3_Inc.
1065059--3/1/2010--USEC_INC
879169--3/5/2010--INCYTE_CORP
1065059--2/26/2009--USEC_INC
879169--3/3/2009--INCYTE_CORP
879169--3/6/2008--INCYTE_CORP
1029142--3/17/2008--DYNAVAX_TECHNOLOGIES_CORP
1103345--3/17/2008--BEACON_POWER_CORP
879169--2/28/2007--INCYTE_CORP
1103345--3/30/2007--BEACON_POWER_CORP
1273013--3/20/2006--PHARMACOPEIA_DRUG_DISCOVERY_INC
1100412--8/12/2010--ARRAY_BIOPHARMA_INC
716646--6/14/2010--CLINICAL_DATA_INC
881524--3/10/2010--VIVUS_INC
1405424--3/29/2010--VISION_INDUSTRIES_CORP
1142596--2/26/2010--NUVASIVE_INC
356591--3/26/2010--NEUROLOGIX_INC/DE
901219--3/2/2010--HUMAN_GENOME_SCIENCES_INC
1095565--3/26/2010--HEALTHSTREAM_INC
related topics
{product, candidate, development}
{product, liability, claim}
{control, financial, internal}
{customer, product, revenue}
{investment, property, distribution}
{tax, income, asset}
{financial, litigation, operation}
{interest, director, officer}
{capital, credit, financial}
{property, intellectual, protect}
{acquisition, growth, future}
{competitive, industry, competition}
{cost, contract, operation}
{gas, price, oil}
{stock, price, share}
{operation, natural, condition}
{system, service, information}
{regulation, government, change}
{product, market, service}
{debt, indebtedness, cash}